DelSiTech Ltd Receives Significant Funding for Developing Long-Acting Injectables Marcus Reay2019-05-21T10:46:27+02:00May 21st, 2019| Read More
DelSiTech Strengthens its Business Development and Alliance Management Capabilities Marcus Reay2019-04-05T08:59:15+02:00April 5th, 2019| Read More
DelSiTech to Present at ARVO 2019 Vancouver, April 28 – May 2 Marcus Reay2019-04-01T17:03:56+02:00March 30th, 2019| Read More
Meet DelSiTech at BIO-Europe Spring 2019 Vienna, March 25-27 Marcus Reay2019-03-08T12:28:11+02:00March 7th, 2019| Read More
DelSiTech Featured in Pharma Technology Article: “2019 is set to be an exciting year for DelSiTech and its Silica Matrix”. Marcus Reay2019-02-25T16:44:40+02:00February 25th, 2019| Read More
DelSiTech and Innovare Sign Licensing Agreement for the Development of a Long Acting HIV Therapy Lasse Leino2019-04-18T14:22:03+02:00December 18th, 2018| Read More
DelSiTech Ltd Receives Funding for the Stabilization of Viral Vaccines – Awarded a grant for vaccine development by the Bill & Melinda Gates Foundation Lasse Leino2018-10-24T11:34:06+02:00October 24th, 2018| Read More
Drug Delivery Company DelSiTech Ltd Announces Appointment of Professor Reijo Salonen to Its Board of Directors admin@delsitech.com2018-03-28T07:56:31+02:00January 4th, 2018| Read More
DelSiTech Ltd and C-Tri Co. Ltd Sign a Collaboration Agreement to Develop Innovative Drug Delivery Technology Product for Oncology admin@delsitech.com2018-03-28T07:56:12+02:00December 18th, 2017| Read More
